Prophylactic Erythropoietin for Neuroprotection in Very Preterm Infants: A Meta-Analysis Update
A meta-analysis update of randomized controlled trials investigating recombinant human erythropoietin suggests improved neurodevelopmental outcome in preterm infants. There was substantial heterogeneity, which could be ascribed to a single trial. Exclusion of this trial featuring a high risk of bias...
Main Authors: | Hendrik S. Fischer, Nora J. Reibel, Christoph Bührer, Christof Dame |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2021.657228/full |
Similar Items
-
Mother-toddler play interaction in extremely, very low birth weight, and full-term children: A longitudinal study
by: Paola Salvatori, et al.
Published: (2016-09-01) -
Successful conservative treatment of intestinal perforation in VLBW and ELBW neonates: a single centre case series and review of the literature
by: Nan Ye, et al.
Published: (2019-07-01) -
Spontaneous Closure of the Ductus Arteriosus in Preterm Infants: A Systematic Review
by: Johan C. A. de Klerk, et al.
Published: (2020-09-01) -
Early Biomarkers of Hypoxia and Inflammation and Two-Year Neurodevelopmental Outcomes in the Preterm Erythropoietin Neuroprotection (PENUT) Trial
by: Thomas R. Wood, et al.
Published: (2021-10-01) -
Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor
by: Carolina Castillo Hernández, et al.
Published: (2017-01-01)